Anterior Cruciate Ligament Repair Market Size

  • Report ID: 4021
  • Published Date: Dec 24, 2024
  • Report Format: PDF, PPT

Anterior Cruciate Ligament Repair Market Size

ACL Reconstruction Market size was valued at USD 7.7 billion in 2024 and is likely to cross USD 14.7 billion by 2037, expanding at more than 5.1% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of ACL reconstruction is estimated at USD 8.03 billion.

Cruciate ligaments, also called cruciform ligaments, are present in the anterior of the knee. During the ACL reconstruction surgery, a surgical tissue graft is used to replace the injured cruciate muscles. The growth of the ACL reconstruction market can be attributed to the increasing prevalence of orthopedic injuries, especially sports-related injuries. Moreover, growing prevalence of bone-related diseases, such as osteoporosis, is estimated to boost the market growth. As the participation in sports in increasing, the incidences of sports injury are also surging across the globe. For instance, a report by the American Academy of Pediatrics suggested that in the U.S., more than 3.5 million children under the age of 14 years get sport injuries annually. Furthermore, the growing awareness amongst the people regarding non-invasive surgeries is also anticipated to boost the market growth. Along with this, the increasing healthcare expenditure worldwide, is expected to boost the market growth. As per the statistics by the World Bank, 9.856% of the global GDP was spent for healthcare in 2018.


Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4021
  • Published Date: Dec 24, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of ACL reconstruction is estimated at USD 8.03 billion.

ACL Reconstruction Market size was valued at USD 7.7 billion in 2024 and is likely to cross USD 14.7 billion by 2037, expanding at more than 5.1% CAGR during the forecast period i.e., between 2025-2037.

Asia Pacific industry is poised to account for largest revenue share by 2037, impelled by increasing cases of osteoporosis and arthritis in the region.

The major players in the market are Arthrex, Inc., DJO, LLC, Smith & Nephew plc, Stryker Corporation, Mylan N.V., Novartis International AG, Johnson & Johnson, GlaxoSmithKline plc, and Merck & Co., Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample